Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mobile CBT vs Flupentixol/Melitracen for Refractory Functional Dyspepsia
NCT06756139Recruiting
- Sponsor
- Air Force Medical University
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Randomised, single-blind trial in functional dyspepsia (FD) (2 arms), sponsored by Air Force Medical University. Primary endpoint: Global Overall Symptom Scale at 8 weeks. Started Nov 2024; status: recruiting.
02
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT06756139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756139.